CPhI Announces 17th Annual CPhI Pharma Awards Winners
The winners were announced during day seven of CPhI Festival of Pharma.
CPhI Worldwide announced the winners of the 17th annual CPhI Pharma Awards on Oct. 13, 2020 during the virtual Festival of Pharma event. The shortlist consisted of 13 different categories spanning across the pharmaceutical supply chain and included a total of 83 finalists of the industry’s companies and individuals. Winners were selected by a panel of independent, senior industry experts.
The winners included:
Excellence in Pharma: Analysis, Testing, and Quality Control
Merck, Blazar platform
Excellence in Pharma: API Development
Micropore Technologies, Membrane Crystallisation
Excellence in Pharma: Contract Services and Outsourcing
Arcinova FlowInova
Excellence in Pharma: Finished Formulation
Lonza Capsugel, Capsugel DBcaps
Highly commended: Uriach Italy—Colpofix
Excellence in Pharma: Manufacturing Technology and Equipment
FabRx, M3DIMAKER
Excellence in Pharma: Drug Delivery Devices
Nemera Safe’n’Spray
Highly commended: Ypsomed, SmartPilot for YpsoMate
Excellence in Pharma: Packaging
SCHOTT Pharmaceutical Systems, SCHOTT Smart Containers
Excellence in Pharma: Regulatory Procedures and Compliance
Affygility Solutions, OEL Fastrac platform
Excellence in Pharma: Supply Chain, Logistics, and Distribution
Controlant, Cold Chain as a Service (ChaaS)
Excellence in Pharma: Digital Innovation
Novartis Pharma Schweiz, The Advanced Myelofibrosis Risk Scoring Tool
Excellence in Pharma: Sustainability
Dr. Reddy’s Laboratories, Watershed Program
Excellence in Pharma: CEO of the Year
Bobby Sheng, Bora Pharmaceuticals
Excellence in Pharma: Innovation in Response to COVID-19
Beximco Pharmaceuticals
Highly commended: Ridgeback Biotherapeutics, MK-4482—in collaboration with Merck
People’s choice—chosen by event attendees
MedPharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
